About Us
Careers
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Your main specialty
Adult & Family Medicine
Allergy, Asthma, Immunology
Anesthesiology
Cardiovascular
Dental
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology & Hepatology
General Surgery
Hematology & Oncology
Infectious Disease
Medical Genetics
Nephrology
Neurology
Neurosurgery
Obstetrics/Gynecology
Ophthalmology
Oral Maxillofacial
Orthopaedics
Otolaryngology
Pathology
Pediatrics
Physical Medicine & Rehab
Plastic Surgery
Podiatry
Preventive Medicine
Psychiatry
Pulmonology
Radiation Oncology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
Clinical Updates in ALL
Clinical Updates in ALL
Playback speed
0.5x
0.75x
1x (Normal)
1.25x
1.5x
1.75x
2x
10 seconds
N
Lecture Summary - Eliminating MRD Prior to HSCT in ALL: Strategies and Considerations
By
Nicholas Short
23 Videos
2 views
September 27, 2022
0 Comments
Login to view comments.
Click here to Login
Clinical Updates in ALL
13:46
SOHO 2022 Tenth Annual Meeting
SOHO 2022: Management of Ph+ ALL in 2022
Feat.
E. Jabbour
06:35
SOHO 2022 Tenth Annual Meeting
SOHO 2022: Phase II Study of Blinatumomab in Combination With Ponati…
Feat.
F. Haddad
12:49
SOHO 2022 Tenth Annual Meeting
SOHO 2022: Approach to Ph-Like ALL
Feat.
E. Curran
09:08
Selina Luger
Approaches to and Use of MRD in ALL
10:33
Lori Muffly
Next Questions: ALL
14:24
Jonathan Webster
2022 NCCN Guidelines Updates on MRD Testing in ALL
01:25
Jonathan Webster
Lecture Summary - 2022 NCCN Guidelines Updates on MRD Testing in ALL
11:51
Emily Curran
Eliminating MRD in Adults With ALL Prior to Transplant: Practical Ap…
10:21
Nicholas Short
Eliminating MRD Prior to HSCT in ALL: Strategies and Considerations
01:10
Nicholas Short
Lecture Summary - Eliminating MRD Prior to HSCT in ALL: Strategies a…
16:32
UChicago Medicine
Personalizing Therapeutic Approaches in Leukemia and Myeloid Maligna…
Feat.
A. Patel
13:56
Hagop Kantarjian
Adult ALL: Progress in Research and Therapy
06:01
ecancer
EHA 2022: Ponatinib & Blinatumomab for Patients With Ph+ ALL
Feat.
N. Short
04:11
Total Health
ASCO 2022 Updates in Leukemia and MDS
Feat.
D. Sallman
04:22
EHA 2022 Conference Coverage
EHA 2022 Tamibarotene in Combination With Ven & Aza in Previousl…
Feat.
E. Stein
06:42
ASCO 2022 Conference Coverage
ASCO 2022 Updates on the Evolution of Asparaginase in the Management…
Feat.
R. Cassaday
56
ASCO 2022 Conference Coverage
Lecture Summary - ASCO 2022 Updates on the Evolution of Asparaginase…
Feat.
R. Cassaday
14:49
Penn Medicine Abramson Cancer Center
The Direction of Leukemia Treatment Nationally and Around the World:…
Feat.
S. Luger
06:25
Hugo Akabane
ALL and Awareness Around MRD
16:32
Rachel Rau
Chemotherapy vs. Blinatumomab in R/R B-ALL
24:40
ASH 2021 Conference Coverage on VuMedi
ASH 2021 Update on MRD in ALL: Standard of Care & Areas for Furt…
Feat.
L. Muffly
15:51
Ryan Cassaday
MRD in Children and Young Adults With High-Risk ALL
08:36
Elias Jabbour
Updates on Treatment Sequencing in ALL
11:32
SOHO 3rd Italian Conference
SOHO Italy 2021: Chemotherapy Free Regimens in Ph+ ALL
Feat.
S. Chiaretti
13:29
Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)
SOHO 2021 Next Questions in ALL
Feat.
B. Shah
13:15
SOHO 3rd Italian Conference
SOHO Italy 2021 on Triple Negative ALL: Past, Present, and Future
Feat.
A. Ferrari
